Baseline
468 results
377 - 468
Ceftazidime/avibactam
Fostemsavir- Voriconazole
Diabetic Kidney Disease- Substance Use in Diabetes
- Voriconazole
- Immune reconstitution inflammatory syndrome (IRIS)
- Atazanavir
- Atazanavir
- Entecavir
- Remdesivir
- Tenofovir DF
- DPP-IV Inhibitors
- Blepharitis
- Entecavir
- Tenofovir DF
- Remdesivir
- Urinary Tract Infection, Complicated (UTI)
- Linezolid
- Pre-exposure Prophylaxis
- Initial Regimen
- Atovaquone
- Antiretroviral Therapy: Treatment-Experienced Patients
- Cryptococcal Meningitis
Selective Serotonin Reuptake Inhibitors (SSRI)- Female Sexual Dysfunction
- Albuminuria
- Rotavirus
- Ceftolozane/tazobactam
- Atovaquone
- Baloxavir
- Mycoplasma pneumoniae
- Cytomegalovirus
- Human papillomavirus (HPV)
- Opioid-Related Disorders
- Staphylococcus aureus
- When to Start Therapy: Chronic HIV Infection
- Niacin
- Chlamydia trachomatis
- Hepatitis B
- Hepatitis C
- Retroviral Syndrome, Acute
- Thiazolidinediones
- Nonalcoholic Fatty Liver Disease
- Key Studies in Diabetes Care: Management of Complications
- Type 2 Diabetes: Sequencing Therapies
- Artificial Pancreas
- Impetigo
- Retroviral Syndrome, Acute
- Screening for and Prevention of Infectious Diseases in Special Populations
- Viekira Pak
- Mycobacterium abscessus
- Viekira Pak
- CMV retinitis
- Zoster vaccine
- Immunomodulating Therapies in Type 1 Diabetes
- Prostatitis, Chronic Bacterial
- Meropenem
- Zoster vaccine
- Mycobacterium leprae
- Leptospira spp.
- Laryngitis
- Pelvic Inflammatory Disease (PID)
- Parainfluenza virus
- Candida albicans
- Abacavir
- Abacavir
- Mastitis
- Ebola virus
- Coccidioides immitis
- Toxoplasma gondii
- Candida spp.
- Key Studies in Diabetes Care: Efficacy of Therapies
- Dengue Virus
- Haemophilus species
- Varicella-zoster virus
- Pseudomonas aeruginosa
- Elderly and Diabetes
- Cytomegalovirus
- JC Virus
- Respiratory syncytial virus
- Treponema pallidum (syphilis)
- Hospital-acquired and ventilator-associated pneumonia
- Saquinavir
- Saquinavir